You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Short-course preoperative radiotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Tumors Trial in Beijing (SCPRT plus neoadjuvant chemo, long course chemoradiation)

Recruiting
  • Rectal Neoplasms
  • SCPRT plus neoadjuvant chemotherapy
  • long course chemoradiation
  • Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Sep 1, 2021

Gastric/Gastroesophageal Junction Adenocarcinoma, Radiotherapy, Immunotherapy Trial (Envafolimab)

Not yet recruiting
  • Gastric/Gastroesophageal Junction Adenocarcinoma
  • +2 more
  • (no location specified)
May 18, 2022

Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • AK104 injection
  • +3 more
  • (no location specified)
Apr 4, 2023

Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • short-course radiotherapy
  • +3 more
  • Daegu, Korea, Republic of
  • +8 more
Jan 8, 2023

Rectal Tumors Malignant, Radiotherapy Trial in Beijing, Shenzhen (drug, radiation, combination product)

Not yet recruiting
  • Rectal Neoplasms Malignant
  • Radiotherapy
  • Beijing, Beijing, China
  • +1 more
Jul 29, 2022

p53 and Response to Preoperative Radiotherapy for T2 and T3

Recruiting
  • Rectal Cancer
  • preoperative short course radiation
  • Vienna, Austria
    Medical University of Vienna, Department of Surgery
Apr 6, 2022

Rectal Tumors Trial in Chengdu, Kunming (preoperative short-course radiotherapy)

Terminated
  • Rectal Neoplasms
  • preoperative short-course radiotherapy
  • Chengdu, Sichuan, China
  • +3 more
Jun 4, 2021

Soft Tissue Sarcomas Trial in Groningen, Leiden, Nijmegen (pre-operative radiotherapy)

Recruiting
  • Soft Tissue Sarcomas
  • pre-operative radiotherapy
  • Groningen, Netherlands
  • +2 more
Aug 3, 2021

Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)

Recruiting
  • Rectal Neoplasms
  • Rectal Neoplasm Malignant
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022

Cancer, Rectum Trial in Beijing (Short-course radiotherapy with neoadjuvant chemo, Long-term chemoradiotherapy)

Recruiting
  • Cancer, Rectum
  • Short-course radiotherapy with neoadjuvant chemotherapy
  • Long-term chemoradiotherapy
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Jul 10, 2021

Neoadjuvant Therapy in Rectal Cancer Trial in Poland, United Kingdom, United States (E7046, Long Course Chemoradiotherapy

Completed
  • Neoadjuvant Therapy in Rectal Cancer
  • Boston, Massachusetts
  • +4 more
Oct 1, 2021

Rectal Cancer Trial in Hangzhou (Envafolimab)

Not yet recruiting
  • Rectal Cancer
  • Envafolimab
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Mar 1, 2023

Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),

Active, not recruiting
  • Rectal Cancer
  • Locally Advanced
  • Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
  • Radiotherapy
  • Tunis, Tunisia
    Amel Mezlini
May 19, 2023

Colorectal Cancer Trial in Napoli (preoperative radiation therapy, Valproic Acid, Capecitabine)

Recruiting
  • Colorectal Cancer
  • preoperative radiation therapy
  • +2 more
  • Napoli, Italy
    Istituto Nazionale Tumori Fondazione G. Pascale
Mar 3, 2021

Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)

Not yet recruiting
  • Locally Advanced Rectal Carcinoma
  • Cadonilimab Injection
  • +2 more
  • (no location specified)
Mar 19, 2023

Rectal Cancer Trial (Short-course radiotherapy combined with furoquintinib and PD-1 mAb)

Not yet recruiting
  • Rectal Cancer
  • Short-course radiotherapy combined with furoquintinib and PD-1 monoclonal antibody
  • (no location specified)
Aug 29, 2023

Rectal Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (Camrelizumab)

Active, not recruiting
  • Rectal Cancer
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Nov 25, 2020

Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced Colon Cancer
  • (no location specified)
Feb 16, 2023

Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Recruiting
  • Early Low Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 9, 2023

Rectal Cancer Trial in Sweden (Short-course RT, Long-course RT)

Completed
Has Results
  • Rectal Cancer
  • Short-course RT
  • Long-course RT
  • Mora, Dalarna, Sweden
  • +17 more
Apr 8, 2021

Rectal Cancer Trial in Stockholm (Radiation therapy)

Recruiting
  • Rectal Cancer
  • Radiation therapy
  • Stockholm, Solna, Sweden
    Karolinska University Hospital, Theme Cancer, Dept of Pelvic can
Aug 15, 2022

Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course

Recruiting
  • Locally Advanced Esophageal Carcinoma
  • Neoadjuvant Chemotherapy
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Jun 21, 2022

Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

Not yet recruiting
  • Locally Advanced Rectal Carcinoma
  • Short course radiotherapy with concurrent capecitabine(825mg/m2)
  • Long course radiotherapy with concurrent capecitabine(825mg/m2)
  • (no location specified)
Jun 24, 2023

Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • Locally Advanced
  • Short-course radiotherapy
  • +3 more
  • (no location specified)
Oct 8, 2022

Locally Advanced Rectal Cancer Trial in Shijiazhuang (Tislelizumab, Short-course radiotherapy, Capecitabine+Oxaliplatin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 1, 2022